MAGI2-AS3

ncRNA information

ncRNA

MAGI2-AS3

Specific or universal ncRNAs

Specific ncRNAs

Class

Long non-coding RNA

Biomarker

None

Biomarker application

Upstream regulatory factor

Not available

Downstream target

Not available

Differential expression in
recurrence vs. nonrecurrence

Down

Cancer information

Cancer name

Hepatocellular Carcinoma

Alias

Liver Cancer

Cancer site

Liver

Recurrence type

Distant recurrence

Clinical information

Overall survival rate of patients with
high ncRNA expression

Not available

ncRNA differential expression in
cancer patients vs. health people

Down

Number of patients

68

Male patients

40

Female patients

28

Age range and number

Not available


Recurrence patients

Not available

Recurrence patients male:female

Not available

Recurrence patients age range

Not available

Recurrence mean age

Not available

Sites of recurrence

Not available


Patients without recurrence

Not available

Patients without recurrence male:female

Patients without recurrence age range

Not available

Patients without recurrence mean age

Not available

Research information

PMID

Description

Our study indicated that MAGI2-AS3 was downregulated in the distant recurrence of HCC after surgical resection and affected the invasion and migration of HCC cells via ROCK2

Tissue resource

plasma of hepatocellular carcinoma patients and the control participants

hepatocellular carcinoma cell lines Hep3B

hepatocellular carcinoma cell lines MHCC97-H

Experiment

qRT-PCR,Western blot


Institute

the affiliate hospital of Qingdao University

American Type Culture Collection

American Type Culture Collection

Country

China

USA

USA

Continent

Asia

North American

North American